High-flow nasal OXYGEN therapy.
Sebastiano MercadanteClaudio AdilePatrizia FerreraFausto GiulianaYasmine GrassiPublished in: BMJ supportive & palliative care (2022)
HFNT may be helpful for severely hypoxaemic patients who are unresponsive to common measures adopted in the last weeks/days of life of patients with advanced cancer or to treat reversible conditions. The findings of this case series showed the ethical and psychological aspects of end of life, particularly for caregivers. Future studies should assess an early use of this device in combination with lower doses of opioids or as an alternative to their use.
Keyphrases
- advanced cancer
- palliative care
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- chronic pain
- stem cells
- pain management
- patient reported outcomes
- respiratory failure
- decision making
- sleep quality
- case control
- patient reported
- extracorporeal membrane oxygenation
- cell therapy
- gestational age
- smoking cessation